LOAd-732

N/A

Report date: 2025/03/20 15:46:33

Base Information

Drug NameLOAd-732
Drug Alias Nametriple CD40 costimulator/4-1BB costimulator/IL-2 agonist/oncolytic adenovirus therapy (Lokon Pharma/Uppsala University/Instituto Catalan de Oncologia)CD40L/4-1BBL/IL-2-expressing oncolytic adenovirus (Lokon Pharma/Uppsala University/Instituto Catalan de Oncologia)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsInterleukin-2 receptor agonistsTumor necrosis factor receptor superfamily member 5 agonists
TargetsInterleukin-2 receptorTumor necrosis factor receptor superfamily member 5Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenSpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUppsala University
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Catalan de OncologiaLokon Pharma AbUppsala University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A